Lupin Atlantis filed suit against Mylan and Ethypharm over two patents related to a prescription drug formulation. 5/12, Western District of Pennsylvania and Eastern District of Pennsylvania, 2:2011cv00630 and 2:2011cv03129.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
